Stockscreener 앱 받기
10.05
7.20%
0.675
시장 영업 전:
10.30
0.25
+2.49%
Transcode Therapeutics Inc 주식(RNAZ)의 최신 뉴스
TransCode Therapeutics Inc. Stock Analysis and ForecastUnprecedented profits - Jammu Links News
Will TransCode Therapeutics Inc. stock benefit from interest rate changesFree Stock Market Forecasting Tools - Newser
What analysts say about CleanCore Solutions Inc. stock outlookSecure Your Capital Strategy - Newser
Is SS Innovations International Inc. stock a good hedge against inflationGroup Only Stock Signals - Newser
Why TransCode Therapeutics Inc. stock attracts strong analyst attentionSmart Money Trade Setups - Newser
RNAZ SEC FilingsTranscode Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
What makes TransCode Therapeutics Inc. stock price move sharplyFree Group Entry - Newser
How TransCode Therapeutics Inc. stock performs during market volatilityFree Stock Market Entry & Exit Signals - Newser
When (RNAZ) Moves Investors should Listen - news.stocktradersdaily.com
TransCode Therapeutics (NASDAQ:RNAZ) Trading 14.9% Higher – Should You Buy? - Defense World
(RNAZ) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Head-To-Head Analysis: TransCode Therapeutics (NASDAQ:RNAZ) vs. Silence Therapeutics (NASDAQ:SLN) - Defense World
TransCode Therapeutics (NASDAQ:RNAZ) Trading 4.7% Higher – Here’s Why - Defense World
TransCode Therapeutics Announces 2025 Annual Meeting Date - TipRanks
(RNAZ) Investment Analysis - news.stocktradersdaily.com
Pre-market Movers: BDTX, CRGX, PASG, RGC... - RTTNews
(RNAZ) On The My Stocks Page - news.stocktradersdaily.com
Transcode Therapeutics Appoints Dr. Phillip D. Zamore To Science Advisory Board - marketscreener.com
TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Science Advisory Board - citybiz
TransCode Therapeutics appoints RNA expert to advisory board - Investing.com
TransCode Therapeutics appoints RNA expert to advisory board By Investing.com - Investing.com Nigeria
TransCode Therapeutics (NASDAQ:RNAZ) Cut to “Sell” at Wall Street Zen - Defense World
Certain Options of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-MAY-2025. - marketscreener.com
Certain Warrants of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-MAY-2025. - marketscreener.com
Certain Common Stock of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 24-MAY-2025. - marketscreener.com
Analysts Offer Insights on Healthcare Companies: Verve Therapeutics (VERV), Nkarta (NKTX) and Kamada (KMDA) - The Globe and Mail
Transcode Therapeutics (RNAZ) Trading Halted Pending News Announ - GuruFocus
Transcode Therapeutics (RNAZ) Trading Halted Pending News Announcement | RNAZ Stock News - GuruFocus
TransCode Therapeutics (RNAZ) Expected to Announce Earnings on Wednesday - Defense World
Abeona Therapeutics (ABEO) Expected to Announce Earnings on Wednesday - Defense World
Intellia Therapeutics (NASDAQ:NTLA) Shares Down 6.1% After Analyst Downgrade - Defense World
Upcoming Stock Splits This Week (May 12 to May 16) – Stay Invested - The Globe and Mail
(RNAZ) Investment Report - news.stocktradersdaily.com
TransCode Therapeutics Successfully Completes Initial Dosing of Patients in Cohort 4 of Phase 1a Clinical Trial; No Dose Limiting Toxicities Reported - Stock Titan
TransCode Therapeutics Faces Nasdaq Delisting Risk - TipRanks
TransCode Therapeutics Announces Reverse Stock Split - TipRanks
TransCode Plans Massive 28:1 Stock Consolidation: What This Means for Your RNAZ Shares - Stock Titan
US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert - Benzinga
TransCode Therapeutics announces reverse stock split - Medical Buyer
Tyson Foods, Ford And 3 Stocks To Watch Heading Into Monday - Benzinga
TransCode Therapeutics Announces 1-for-28 Reverse Stock Split - citybiz
Is rnaz a good buy - AInvest
TransCode Therapeutics approves reverse stock split to meet Nasdaq rules By Investing.com - Investing.com India
TransCode Therapeutics (RNAZ) Plans 1-for-28 Reverse Stock Split - GuruFocus
Offerings News Live Feed - Stock Titan
Transcode Therapeutics Announces 1-For-28 Reverse Stock Split - marketscreener.com
TransCode Therapeutics (RNAZ) Announces 1-for-28 Reverse Stock Split - GuruFocus
TransCode Therapeutics approves reverse stock split to meet Nasdaq rules - Investing.com
TransCode Therapeutics approves 1-for-28 reverse stock split; shares fall - MSN
TransCode Therapeutics (RNAZ) Plans 1-for-28 Reverse Stock Split | RNAZ Stock News - GuruFocus
TransCode Therapeutics to Implement 1-for-28 Reverse Stock Split - marketscreener.com
TransCode Plans Major 1:28 Reverse Split, Slashing Shares from 23M to 833K for Nasdaq Listing - Stock Titan
TransCode Stock Rallies On Promising Metastatic Cancer Drug Trial: Retail Sees More Upside - MSN
For Dropbox Inc [DBX], Analyst sees a drop to $30. What next? - dbtnews.com
Direct Digital Holdings Inc [DRCT] is -44.37% lower this YTD. Is it still time to buy? - dbtnews.com
0.64%
0.37%
자본화:
|
볼륨(24시간):